Cargando…

New Insights into the Mechanism of the Down-Regulation of Mast Cells in the Treatment of Interstitial Cystitis: Possible Role of Siglecs

Detalles Bibliográficos
Autor principal:	Lee, Tack
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Continence Society 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138844/ https://www.ncbi.nlm.nih.gov/pubmed/21811693 http://dx.doi.org/10.5213/inj.2011.15.2.59

Ejemplares similares

Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis
por: Park, Chang-Shin, et al.
Publicado: (2011)

Interleukin-33 as a Potential Therapeutic Target for Interstitial Cystitis: New Perspectives on Mast Cell Regulation
por: Choo, Min Soo
Publicado: (2015)

Metabolomics Insights Into Pathophysiological Mechanisms of Interstitial Cystitis
por: Fiehn, Oliver, et al.
Publicado: (2014)

The importance of mast cells in interstitial cystitis/bladder pain syndrome
por: Ratner, Vicki
Publicado: (2016)

Animal Model of Interstitial Cystitis/Bladder Pain Syndrome
por: Kwon, Whi-An
Publicado: (2018)

Angiogenic factors, bladder neuroplasticity and interstitial cystitis—new pathobiological insights
por: Saban, Ricardo
Publicado: (2015)

Interstitial Cystitis/Bladder Pain Syndrome: A Urologic Mystery
por: Cho, Young Sam
Publicado: (2016)

Mast cell activation syndrome in pain syndromes bladder pain syndrome/interstitial cystitis and vulvodynia
por: Regauer, Sigrid
Publicado: (2016)

Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells
por: Robida, Piper A., et al.
Publicado: (2022)

Human Umbilical Cord Mesenchymal Stem Cell Therapy Mitigates Interstitial Cystitis by Inhibiting Mast Cells
por: Xu, Yuancheng, et al.
Publicado: (2021)

Editorial: Special Issue “Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)”
por: Neuhaus, Jochen, et al.
Publicado: (2022)

Co-Morbidities of Interstitial Cystitis
por: Chelimsky, Gisela, et al.
Publicado: (2012)

Interstitial cystitis intravesical therapy
por: Ha, Tanya, et al.
Publicado: (2017)

A new player in interstitial cystitis/bladder pain syndrome: platelet‐activating factor – PAF and its connection to smoking
por: Kullmann, Florenta Aura
Publicado: (2017)

Development of the Interstitial Cystitis Self-Help and Medical Resources Scale (ICSR) for Women with Interstitial Cystitis
por: Chen, Hui-Chun, et al.
Publicado: (2022)

Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice
por: Wei, Yadong, et al.
Publicado: (2018)

Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells
por: Schanin, Julia, et al.
Publicado: (2022)

Potential Use of Antiproliferative Factor as a Targeting Therapy in Painful Bladder Syndrome/Interstitial Cystitis
por: Kim, Khae Hawn
Publicado: (2011)

Molecular Mechanisms and Key Processes in Interstitial, Hemorrhagic and Radiation Cystitis
por: Brossard, Clément, et al.
Publicado: (2022)

Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis
por: Kind, Tobias, et al.
Publicado: (2016)

Current guidelines in the management of interstitial cystitis
por: Colaco, Marc, et al.
Publicado: (2015)

How does interstitial cystitis begin?
por: Parsons, C. Lowell
Publicado: (2015)

An update on treatment options for interstitial cystitis
por: Garzon, Simone, et al.
Publicado: (2020)

Current role of neuromodulation in bladder pain syndrome/interstitial cystitis
por: Padilla-Fernández, Bárbara, et al.
Publicado: (2022)

Mast Cell-Derived Histamine Mediates Cystitis Pain
por: Rudick, Charles N., et al.
Publicado: (2008)

Non-Hunner's Interstitial Cystitis Is Different from Hunner's Interstitial Cystitis and May Be Curable by Uterosacral Ligament Repair
por: Goeschen, Klaus, et al.
Publicado: (2022)

Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells
por: Yu, Yingxin, et al.
Publicado: (2018)

The Use of Urine Proteomic and Metabonomic Patterns for the Diagnosis of Interstitial Cystitis and Bacterial Cystitis
por: Van, Que N., et al.
Publicado: (2004)

Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome
por: Grundy, Luke, et al.
Publicado: (2018)

To reveal pharmacological targets and molecular mechanisms of curcumol against interstitial cystitis
por: Wu, Ka, et al.
Publicado: (2019)

Immunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle
por: Ren, Xiubao
Publicado: (2019)

Role of cystoscopy and hydrodistention in the diagnosis of interstitial cystitis/bladder pain syndrome
por: Ens, Gisela, et al.
Publicado: (2015)

From interstitial cystitis to chronic pelvic pain
por: Persu, C, et al.
Publicado: (2010)

Recent advances in imaging and understanding interstitial cystitis
por: Tyagi, Pradeep, et al.
Publicado: (2018)

Interstitial cystitis: an enigmatic disorder of unclear aetiology
por: Moutzouris, Dimitrios-Anestis, et al.
Publicado: (2008)

Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis
por: Mykoniatis, Ioannis, et al.
Publicado: (2022)

MCP-1-Induced Histamine Release from Mast Cells Is Associated with Development of Interstitial Cystitis/Bladder Pain Syndrome in Rat Models
por: Lv, Jianwei, et al.
Publicado: (2012)

Urinary Metabolite Profiling Combined with Computational Analysis Predicts Interstitial Cystitis-Associated Candidate Biomarkers
por: Wen, He, et al.
Publicado: (2014)

Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs
por: Angata, Takashi
Publicado: (2018)

New Aspects in the Differential Diagnosis and Therapy of Bladder Pain Syndrome/Interstitial Cystitis
por: Neuhaus, Jochen, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ji6ksn9af1tvaug25stvf85b8l